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http://www.biomedcentral.com/1471-2164/15/72RESEARCH ARTICLE Open AccessThe global effect of follicle-stimulating hormone
and tumour necrosis factor α on gene expression
in cultured bovine ovarian granulosa cells
Claire Glister1, Nicholas Hatzirodos2, Katja Hummitzsch2, Philip G Knight1 and Raymond J Rodgers2*Abstract
Background: Oocytes mature in ovarian follicles surrounded by granulosa cells. During follicle growth, granulosa
cells replicate and secrete hormones, particularly steroids close to ovulation. However, most follicles cease growing
and undergo atresia or regression instead of ovulating. To investigate the effects of stimulatory (follicle-stimulating
hormone; FSH) and inhibitory (tumour necrosis factor alpha; TNFα) factors on the granulosa cell transcriptome,
bovine ovaries were obtained from a local abattoir and pools of granulosa cells were cultured in vitro for six days
under defined serum-free conditions with treatments present on days 3–6. Initially dose–response experiments
(n = 4) were performed to determine the optimal concentrations of FSH (0.33 ng/ml) and TNFα (10 ng/ml) to be
used for the microarray experiments. For array experiments cells were cultured under control conditions, with FSH,
with TNFα, or with FSH plus TNFα (n = 4 per group) and RNA was harvested for microarray analyses.
Results: Statistical analysis showed primary clustering of the arrays into two groups, control/FSH and TNFα/TNFα
plus FSH. The effect of TNFα on gene expression dominated that of FSH, with substantially more genes differentially
regulated, and the pathways and genes regulated by TNFα being similar to those of FSH plus TNFα treatment.
TNFα treatment reduced the endocrine activity of granulosa cells with reductions in expression of FST, INHA, INBA
and AMH. The top-ranked canonical pathways and GO biological terms for the TNFα treatments included antigen
presentation, inflammatory response and other pathways indicative of innate immune function and fibrosis. The
two most significant networks also reflect this, containing molecules which are present in the canonical pathways
of hepatic fibrosis/hepatic stellate cell activation and transforming growth factor β signalling, and these were up
regulated. Upstream regulator analyses also predicted TNF, interferons γ and β1 and interleukin 1β.
Conclusions: In vitro, the transcriptome of granulosa cells responded minimally to FSH compared with the
response to TNFα. The response to TNFα indicated an active process akin to tissue remodelling as would occur
upon atresia. Additionally there was reduction in endocrine function and induction of an inflammatory response to
TNFα that displays features similar to immune cells.
Keywords: Ovary, Microarray analysis, Bovine granulosa cells, FolliclesBackground
An ovarian primordial follicle is composed of an inactive
oocyte surrounded by granulosa cells all enclosed by a
basal lamina. The granulosa cells of the ovarian follicle
support and nurture the oocyte, and secrete oestrogens
which are necessary for normal reproductive function.* Correspondence: ray.rodgers@adelaide.edu.au
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reproduction in any medium, provided the orIn mammals, the latter stage of follicle development can
involve an approximate hundred fold increase in diam-
eter, 21 doublings of granulosa cell numbers [1] and for-
mation of a fluid-filled antrum [2]. In cattle, the growth
of follicles is tightly regulated, since two or three groups
or waves of follicles emerge from a pool of follicles lar-
ger than 5 mm in diameter during each oestrous cycle
[3,4]. In these waves, follicles continue to enlarge over
several days until one follicle grows faster and larger
than the others and hence gains ‘dominance’ [5,6]. This
deviation in size occurs when the follicles are aroundtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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growth occur largely due to the stimulatory influence of
FSH, through its receptor localised exclusively to the
granulosa cells, though other factors produced locally,
for example Growth Differentiation Factor (GDF)-9 [8]
and Bone Morphogenetic Protein (BMP)-15 from the
oocyte [9], are also involved.
Instead of one primordial follicle growing to ovulatory
size and then ovulating, many follicles commence growing
during the course of the cycle. Most of these growing folli-
cles become atretic, resulting in cows and humans, in only
one or occasionally two follicles ovulating each cycle. The
highest rates of atresia in follicular development occur
around the time of antrum formation. It has been shown
that the atretic process begins with cell death in the mem-
brana granulosa initially by an apoptotic process [10].
Generally, apoptosis may be instigated intracellularly by
cytotoxic stress, possibly due to free radicals or calcium
influx [11] which cause mitochondrial changes that even-
tually also lead to caspase activation. Apoptosis can be ini-
tiated externally to the cell by the binding of ‘death’
ligands such as Fas ligand, tumour necrosis factor α
(TNFα) or TRAIL to specific receptors [12]. In follicular
atresia it is unlikely that cell death occurs on a cell-by-cell
basis because numerous pyknotic nuclei are observed dur-
ing atresia [10]. Therefore it is probable that atresia is ini-
tiated by either the presence or absence of a particular
external signal(s). TNFα can initiate apoptosis in granulosa
cells [13,14]. The expression of TNFα receptors on granu-
losa and theca cells has been shown to be increased in
atretic follicles when compared with healthy small or pre-
ovulatory follicles [15]. Studies on atretic follicles so far
have shown that many of the genes/pathways involved are
common to those stimulated by TNFα, as recently
reviewed by Matsuda et al. [16].
Investigation of the effects of various agents on granulosa
in vitro is dependent on the follicle stage at which the cells
were isolated and the composition of the culture medium.
It has been demonstrated that granulosa from small antral
follicles are more responsive to FSH in serum-free culture
and are capable of increasing oestradiol production over a
six day period [17,18]. This is an important consideration
for studying granulosa cells as they have a propensity to
differentiate into granulosa-lutein cells in a process called
luteinisation, if cultured in serum-supplemented medium
[19]. Such cells are completely unresponsive to FSH. A
previous study showed that TNFα was able to block the ef-
fects of FSH in serum-free culture of rat granulosa cells
[20]. We were interested in the effect of FSH and TNFα on
steroid production and global gene expression in bovine
granulosa cells to help elucidate the mechanisms of action
of these compounds at the transcriptional level. Interest in
the action of pro-inflammatory signals like TNFα has been
augmented by recent reports that ovarian granulosa cellsof cattle and other species fulfil an innate immunity role,
being capable of detecting and responding to bacterial
pathogens [21]. We therefore cultured granulosa cells from
small bovine follicles with or without FSH and TNFα,
alone and in combination, assayed steroid hormone pro-
duction by immunoassay and conducted microarray ana-
lyses using Genechip bovine genome arrays.
Results
Cell culture and hormone assays
A dose response culture experiment was performed to
determine the optimal concentrations of FSH and TNFα
(Figure 1) to be used for the microarray experiments.
On the basis of this experiment it was shown that
oestradiol production was highest with a FSH dose of
0.33 ng/ml, being significantly different from values ob-
served at all other FSH concentrations in the absence of
TNFα. Ten ng/ml of TNFα was sufficient to reduce this
effect to the control level. Progesterone levels and viable
cell number at the end of the culture period were not
significantly (P > 0.05) affected by either FSH or TNFα
treatment. On the basis of these results, 0.33 ng/ml FSH
and 10 ng/ml TNFα were selected for the culture of cells
to be used for microarray analyses.
The results of the hormone secretion in the cultures of
granulosa cells which were used for the microarray analyses
are shown in Figure 2. FSH stimulation of the cultures
produced a greater than 20-fold induction (P < 0.05) of
oestradiol secretion by the granulosa cells compared with
the control cells (Figure 2). Conversely, TNFα treatment
caused a > 65% reduction in the amount of oestradiol secre-
tion under basal conditions (P < 0.05) and completely abol-
ished the FSH-induced rise in oestradiol secretion (P < 0.05).
Progesterone levels averaged approximately 200 ng/ml
across all cultures, trending higher for the FSH-treated cul-
ture, but no significant differences were observed between
the treatments (Figure 2). This confirms that the cultured
granulosa cells maintained a hormone production profile
characteristic of non-luteinised cells, and responded to FSH
and TNFα as anticipated.
Hierarchical clustering and principal component
analyses (PCA)
These analyses were performed on the sixteen microarrays,
four from each treatment group, as presented in Figure 3
(PCA) and Additional file 1: Figure S1 (hierarchical cluster-
ing). These figures show that culture sample G9 from the
‘control’ group was quite different in signal intensity across
most probe sets on the chip from the other controls, and in
fact all other arrays. This result prompted us to consider
this array as a statistical outlier, and it was excluded from
further analyses. The other arrays formed two clusters on
the basis of distribution of signal intensity, the ‘TNFα and
TNFα + FSH’ groups (B in Figure 3), and the ‘control and
Figure 1 Dose response effects of FSH and TNFα. Oestradiol (A),
progesterone (B) and cell numbers (C) in cultured granulosa cells.
The data represent the mean ± SEM (n = 4). Cell numbers represent
viable cells per ml at the end of culture. The axes are logarithmically
scaled. *indicates significantly different from controls (two-way
ANOVA with Fisher’s LSD post hoc test, P < 0.05).
Figure 2 Concentrations of hormones from granulosa cells
cultured for microarray analyses. Oestradiol (A) and progesterone
(B) measured in media from cells cultured in the presence or absence
of 0.33 ng/ml FSH and 10 ng/ml TNFα (n = 4 each). The axes
are logarithmically scaled. Mean concentrations of oestradiol ± SEM
in ng/ml for the different treatments were: 0.8 ± 0.2 (control), 0.2 ± 0.1
(TNFα), 22.4 ± 6.7 (FSH) and 0.3 ± 0.1 (TNFα + FSH). Corresponding
values for progesterone were: 167 ± 29 (control), 187 ± 40 (TNFα),
289 ± 91 (FSH) and 243 ± 63 (TNFα + FSH). Significantly different
values (two-way ANOVA with Fisher’s LSD post hoc test, P < 0.05)
are indicated by different letters.
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the TNFα and the TNF + FSH-treated groups (n = 8), and
then for the control and the FSH-treated groups (n = 7). In
both cases, for each comparison no differences were ob-
served between the FSH treated and the non FSH-treatedcells (Additional file 2: Figure S2). ANOVA demonstrated
that no genes were different by more than 2-fold with an
FDR of P < 0.05. We can therefore assume that under our
experimental culture conditions, FSH alone did not have a
substantial effect on granulosa cell total gene expression,
whereas TNFα had a major effect and actually overrode
any effects of FSH when treated in combination.
Quantitation of gene expression by RT-PCR
Figure 4 shows the quantitative RT-PCR results for some
of the genes which were significantly affected by FSH and/
or TNFα treatment of granulosa cells in culture: FSHR
(A), the steroidogenic genes CYP19A1 (F), CYP11A1 (C),
HSD3B1 (D), HSD17B1 (E) and STAR (B), and other genes
INHA (G), INHBA (H) and FST (I). These genes are
known to be active during antral follicular expansion when
Figure 3 Unsupervised PCA of the granulosa cell arrays using
Partek. The arrays are numbered (n = 4 per treatment) as follows:
control granulosa (G1, G5, G9 and G13 in grey); FSH-treated (G2, G6,
G10 and G14 in blue); TNFα-treated (G3, G7, G11 and G15 in red)
and TNFα plus FSH-treated (G4, G8, G12, and G16 in black). The
graph is a scatter plot of the values for the first (X) and second (Y)
principal components based on the correlation matrix of the total
normalised array intensity data. The groups of arrays (A) and (B),
encircled by the dotted lines, represent related arrays based on
patterns of total gene expression determined from the PCA. The G9
array had a considerably different pattern of gene expression from
all the others and was therefore considered to be a statistical outlier
and excluded from further analysis.
Glister et al. BMC Genomics 2014, 15:72 Page 4 of 15
http://www.biomedcentral.com/1471-2164/15/72the granulosa cells are responsive to higher levels of FSH
[22,23]. All genes except STAR, CYP11A1 and HSD3B1 were
up regulated by FSH treatment alone. TNFα, whether alone
or in combination with FSH, decreased expression of the
following genes below the level of the control: FSHR, STAR,
INHA, INHB and FST and the steroidogenic genes
HSD17B1 and CYP19A1 to the level of the control. The de-
crease in CYP19A1, the gene encoding aromatase, the key
enzyme of oestradiol synthesis, explains the observed de-
cline in oestradiol production in the cultures under the in-
fluence of TNFα (Figure 2).
Differential gene expression analyses
Comparison of all treatments against the control group
by ANOVA with a three-fold change and a statistical
cut-off of P < 0.05 produced a differentially-regulated list
of 288 genes for the TNFα-treated arrays compared with
the controls, and 232 genes were common to both TNFα
datasets and regulated in the same direction and to ap-
proximately the same degree (Additional file 3: Figure
S3 and Additional file 4: Table S1). These numbers re-
flect the results of the unsupervised statistical analyses.
Although FSH was shown by qRT-PCR and microarray
analyses to statistically alter a number of specific genes(Figure 2), comparison of all treatments by ANOVA de-
termined that no genes were differentially regulated by
FSH treatment more than 2 fold with an FDR of P < 0.05.
Additionally the hierarchical clustering and PCA analyses
(Figure 3 and Additional file 1: Figure S1) did not indicate
any major effects of FSH. We therefore compared TNFα ±
FSH treated cultures (n = 8) with the control ± FSH treated
cultures (n = 7) and generated lists of differentially ex-
pressed genes as shown in Table 1. Lists of genes which
were three-fold differentially expressed between these con-
ditions are presented in Tables 2 and 3 and the full annota-
tions of these genes are presented in Additional file 5: Table
S2. This list was imported into Ingenuity Pathway Analysis
(IPA) and Gene Ontology Enrichment Analysis Software
Tool Kit (GOEAST) for functional pathway and network
analyses.
IPA and GO enrichment analysis of TNFα regulated dataset
Genes from the dataset that were differentially regulated >
3 fold and P < 0.05 between TNFα ± FSH and control ±
FSH were mapped to canonical pathways in IPA and shown
in Figure 5A. Many of the pathways were associated with
immune cell function and inflammatory response pathways.
Several of these pathways contain genes such as the nuclear
factor-kappa- B complex (NF-κB) genes, NFKB1A and
NFKB2, interleukin receptor 1 and the cell survival gene
PIK3R1. The GO enrichment analysis for this dataset
(Figure 5B), also showed over-representation of processes
such as antigen presentation, inflammation and stress
response.
We also used IPA upstream regulator analysis to identify
upstream transcriptional regulators. Upstream regulators
were predicted using a Fisher’s exact t-test to determine
the probability that genes from the dataset correspond
with targets which are known to be activated or inhibited
by those molecules based on current knowledge in the In-
genuity database. Table 4 reveals a number of upstream
regulators which were predicted to be influenced by TNFα
treatment. It contained the inflammatory response media-
tors IL1B and IF1B, and the matrix encoding gene FN1.
Interestingly, the interleukin receptor antagonist IL1RN
was predicted to be down regulated, but it was shown to
be up regulated according to the array intensity data.
The two highest scoring gene networks generated in
IPA from our dataset for the effect of TNFα on the cul-
tured granulosa are displayed in Figure 6. Network A
shows an emphasis on innate immune response genes
including several which are induced by interferon such
as IFIT2, IFI44, IFIH1 and IFI27, which are all up regu-
lated. Other genes in this network have some involve-
ment with apoptotic signalling, namely RIPK4, FOXS1
and BEX2. The molecule(s) forming most interactions in
this network is the NF-κB complex, located within the
nucleus. The other network (B) shows a focus around
Figure 4 Gene expression by qRT-PCR. The data are shown on a log scale as the mean ± SEM (n = 4 each, except microarray control group
n = 3) for the ratio of gene expression with treatments relative to control (set at 1.0). qRT-PCR values were determined from the ΔΔCt for the
target genes (A – I), relative to β-actin (ACTB), and the microarray values are signal intensities (normalised but not log transformed). Significantly
different results for treatments used one-way ANOVA with Fisher’s LSD post hoc test; P < 0.05.
Table 1 The number of probe sets which were
differentially regulated between control (± FSH) and
TNFα (± FSH)-treated granulosa cell cultures
Fold change Up regulated Down regulated Total
>2 869 463 1332
>3 400 127 527
>4 234 161 295
>6 107 12 119
>10 40 0 40
Numbers were determined by a one-way ANOVA with a FDR P < 0.05 for
multiple comparisons using Partek.
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PDGF, COL16A1 and ADAMTSL4. There is also con-
nectivity with the down-regulated genes INHA, INHBA
and FST, which are all known to play a role in folliculo-
genesis as previously mentioned. Other genes which
were highly activated due to TNFα treatment (Table 2 and
Additional file 4: Table S1), included GPR77 and SLP1
(55-fold up regulated), PRKCB (20-fold), COL6A1 (13-
fold), KRT8 (10-fold) and HSD11B1 (6-fold). Amongst the
down-regulated group of genes, CHST8 (8-fold) (Table 3
and Additional file 4: Table S1) may have a novel intra-
follicular role.
Discussion
This study examined the effects of the treatment with
FSH and TNFα, separately or combined, on granulosa
Table 2 Genes which were >3-fold up regulated in TNFα (± FSH)-treated granulosa cells compared with control
(± FSH) cells
Gene
symbol
Fold change Gene
symbol
Fold change Gene
symbol
Fold change
(TNFα vs non TNFα treated) (TNFα vs non TNFα treated) (TNFα vs non TNFα treated)
Cell death
TGM2 31 XAF1 6.8 IER3 3.6
CASP4 15.2 BCL2A1 5.3 PYCARD1 3.3
IFI6 9.2 SAMD9 4.9 TNFSF13B 3.2
BEX2 8.6 EGLN3 4.5 RIPK4 3.1
BIRC3 8.6 TRAF1 4.3
Cell morphology
KRT8 10 ERP27 3.5 NCK2 3.1
STMN2 7.7 PDPN 3.5 TACC1 3.1
MAP2 4.7 FMNL3 3.4 GPHN 3.0
DCLK1 4.5 MSN 3.4 MFAP2 3.0
KRT18 4.2 EMP3 3.3
Cytokines, hormones and receptors
GPR77 61.5 CD83 6.3 PLAUR 3.8
CD44 21.5 ROBO1 6.1 HLA-DQA1 3.7
IFI44 14.9 IFIT2 6.0 NTRK1 3.6
CD19 14.2 HLA-A 5.9 IL36A 3.6
IFI16 13.6 HLA-DQA2 5.9 EMR3 3.5
PTGER4 13.2 IL1RN 5.9 TCRA 3.5
CCL2 13.1 GPR68 5.2 TGFB1 3.5
SLCO4A1 12.3 HLA-DMB 5.0 GKN2 3.4
CD200 10.8 ICAM1 4.7 IFITM1 3.4
CXCL10 10.8 HLA-DRA 4.6 HLA-DRB3 3.3
CD40 10.1 LYVE1 4.6 FGF2 3.2
IFI27 9.5 IL1R1 4.5 VIPR2 3.2
PLXND1 9.4 NR4A2 4.3 GPR56 3.1
IFIH1 7.1 OLR1 4.0 CD72 3.1
JAG1 6.7 NRG1 3.9 IGF2 3.1
CCL5 6.4 PDGFB 3.8
Extracellular matrix and synthesis
TNC 52.3 COL15A1 9.4 FMOD 4.0
COL6A1 14.5 COL16A1 5.0 AGRN 3.8
LOXL4 8.8 COL5A3 4.6 FN1 3.3
Intercellular and cell to matrix adhesion
BST2 6.4 THBS3 3.6 CEACAM8 3.2
VCAM1 5.3 SPP1 3.6 CDH1 3.1
CD82 4.8 CD9 3.6
ITGA5 4.5 NUAK2 3.4
Ion transport
KCNMA1 8.9 FXYD3 3.9 CLCA3P 3.1
CACNA1G 6.9 GRIA3 3.7 SLC25A12 3.0
CNGA3 4.3 TPCN1 3.4
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Table 2 Genes which were >3-fold up regulated in TNFα (± FSH)-treated granulosa cells compared with control
(± FSH) cells (Continued)
Proteolysis and inhibition
SLPI 58.6 MMP2 5.0 CTSH 3.5
UBD 17.1 PSMB10 3.9 TFPI2 3.5
SERPINB2 14.9 PSMB8 3.8 TRIM21 3.2
SERPINA5 12.5 ADAMTSL4 3.8 UBA7 3.2
ISG15 10.8 ERAP2 3.8 PRSS2 3.1
ADAM23 8.3 USP18 3.7 CFD 3.1
A2M 5.6 TIMP3 3.7 CSTB 3.1
PSMB9 5.1 C1S 3.6
Transcriptional regulation
GFI1 14.1 IRF1 4.7 NFKB2 3.7
NFKBIA 9.8 HEYL 4.7 NFKBIZ 3.6
FOXA3 9.0 HES4 4.6 H19 3.5
MYB 8.4 IRF8 4.2 SNAI1 3.4
MIR147 5.3 LRRFIP1 4.0 NOSTRIN 3.4
TBX3 5.2 NUPR1 4.0 DTX1 3.3
BHLHE40 4.8 RBPMS 3.9 FOXS1 3.3
TCF7 4.8 IKZF3 3.8 STAT5A 3.1
Transport
RTP4 14.5 RAB3IP 3.8 SLC37A1 3.5
ABCC3 8.0 ANKH 3.7 SLCO2A1 3.4
TF 4.1 TAP1 3.5 SYNGR1 3.1
Other enzymes
PRKCB 19.3 PNPO 5.0 TPST2 3.9
PTGIS 12.2 PIK3CD 5.0 PRKCQ 3.9
ALDH1A3 11.7 GBP4 4.8 CA5B 3.8
OAS2 10.5 MIOX 4.7 PARP14 3.7
PON3 9.3 ADCY2 4.7 PARP12 3.7
DDC 8.7 ADH6 4.5 LRAT 3.5
IDO1 7.7 UMPS 4.4 CKB 3.4
MX2 7.5 CA2 4.4 CAMK1D 3.3
HSD11B1 7.0 RSAD2 4.3 FBP1 3.3
MX1 6.6 PPP2R3C 4.3 PARP9 3.2
OAS1 5.5 BCAT2 4.3 PNKD 3.2
ABHD3 5.2 SQRDL 4.1 CA8 3.1
GLDC 5.2 ISG20 4.0
XDH 5.2 APOBEC3B 3.9
Other signalling
ENTPD3 17.7 DNER 5.8 ARHGAP24 4.8
ARHGEF5 13.6 RASAL1 5.2 DDX58 3.3
NFKB1A 9.8 TNIP1 5.5 WNT11 3.2
ARHGAP29 8.7 ARHGEF11 5.1 NKG7 3.4
ANXA8L1 8.0 ARRDC2 4.3 CDC42EP1 3.3
SLAMF8 7.4 RGS16 4.1 PDE4B 3.5
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Table 2 Genes which were >3-fold up regulated in TNFα (± FSH)-treated granulosa cells compared with control
(± FSH) cells (Continued)
TAC3 8.7 SHISA3 4.1 IFI30 3.2
GAL 4.6 GBP5 4.0 RNF128 3.0
DAPP1 5.0 ARHGDIB 3.8
Other
TREM1 11.2 TMEM45B 4.6 DPY19L1 3.6
PLAC8 7.7 MS4A8B 4.6 NELL2 3.6
PARM1 6.5 SAA3 4.6 TMEM140 3.4
EPB41L3 6.3 SELENBP1 4.4 CCDC85C 3.4
FATE1 6.2 CRYBB1 4.4 OAF 3.2
TRIM47 5.4 HPCAL1 4.2 TMED6 3.2
SPARCL1 5.4 UNC13D 4.0 ABTB2 3.2
NUCB2 5.2 EPSTI1 3.9 CRIP2 3.2
PDLIM4 4.8 HSPB6 3.8 CSRP2 3.1
Genes are categorised by function and listed in descending order of fold change in each category. The association of genes with functional terms in this table
was determined manually for each gene based on information obtained through the Entrez Gene database of NCBI. The level of fold change and statistical
significance ( ≥ 3-fold change, P < 0.05) were determined using the step up Benjamini-Hochberg post-hoc test for multiple corrections following one way ANOVA.
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tained in a non-luteinised state. The effect of FSH alone
at 0.33 ng/ml paralleled the result of a previous study by
Glister et al. [17], with similar increases in oestradiol
production and expression of follistatin and inhibin A
confirming the robustness of this physiologically relevant
in vitro model used in the current experiments. More-
over, our qRT-PCR findings confirmed the ability of FSH
to up regulate expression of its cognate receptor (FSHR)
as reported previously [23,24] although a statistically sig-
nificant difference was not detected by microarray ana-
lysis. With the exception of FSHR, there was excellent
agreement between microarray and qRT-PCR data with
respect to treatment effects on the other eight tran-
scripts used for validation purposes. The ability of TNFα
to suppress the production of oestradiol in our experi-
ment was also expected from results of previous studies
in serum-free [13] and serum-supplemented [15] culture
systems.
The unsupervised array analyses and the numbers of
genes differentially regulated, show surprisingly perhaps,
that in our experiment FSH alone had a minor effect on
total gene expression, compared with TNFα, where
many genes were differentially regulated. The effects of
FSH were limited to stimulation of energy metabolism
and steroidogenesis in overall terms, in comparison with
TNFα which mainly influenced inflammatory pathways
and molecules. Clearly the main specific effect of FSH
treatment was to stimulate oestradiol production by up
regulation of aromatase expression (CYP19A1). The pro-
duction of oestradiol and the concomitant activation of
the folliculogenesis regulating genes for inhibin A andfollistatin occur through recognised FSH cascade signal-
ling involving cyclic AMP and protein kinase A [24].
The relatively low dose of FSH (0.33 ng/ml) used to treat
the cells in our microarray experiment was selected as
being optimal for promoting oestradiol secretion and
was insufficient to induce an increase in progesterone
synthesis or proliferation of the granulosa cells in cul-
ture. However, there was transcriptional activation of the
cyclin B1 and B2 genes, which indicates an increase in
mitotic activity, although a net increase in cell number
was not observed under the culture conditions used.
The endocrine functions of granulosa cells appeared to
be down regulated upon TNFα treatments with reduc-
tions in FST (6.2 fold), INHA (5.8 fold), INBA (5.8 fold),
AMH (3.4 fold).
CHST8 was also down regulated in the TNFα-
responsive datasets. The encoded enzyme is a sulphur
transferase that sulphates N-acetylgalactosamine β1,4
linked with N-acetylglucosamine (LacdiNAc) moieties
on certain glycoproteins prior to secretion [25]. Sulpha-
tion of these structures can modulate the activity of
these molecules by affecting the kinetics of binding [26]
and increases their rate of clearance from the body [27].
Glycodelin, an immune mediator, is produced by the
granulosa cells at antral stages and possesses these Lac-
diNAc moieties. Glycodelin is taken up by the cumulus
cells, where it is deglycosylated, loses immunosuppres-
sive function and acquires properties beneficial to the
fertilisation process [28]. It may be possible that sulpha-
tion may also play a role in determining the activity of
glycodelin, but confirmation of this would require fur-
ther investigation.
Table 3 Genes which are >3-fold down regulated in TNFα (± FSH)-treated granulosa cells compared with control
(± FSH) cells
Gene
symbol
Fold change Gene
symbol
Fold change Gene
symbol
Fold change
(TNFα vs non TNFα treated) (TNFα vs non TNFα treated) (TNFα vs non TNFα treated)
Apoptosis
TRIB2 5.7
Cell morphology
DACT1 4.1 ACTG2 3.3 MYO1B 3.1
Cytokines, hormones and receptors
ROBO2 7.9 HEG1 5 PTN 3.5
EFNA5 7.3 PLXNC1 4.4 AMH 3.4
FST 6.2 PPARG 4.2 NR5A2 3.1
INHA 5.8 ANGPT2 3.8 KIT 3
INHBA 5.8 CD36 3.6
NMB 5.5 EPHA7 3.6
Extracellular matrix and synthesis
SPOCK2 5.0 FBLN5 4.8 EFEMP1 3.3
SRGN 5.5
Intercellular and cell to matrix adhesion
CYR61 5 CAV1 4.1 CTNNAL1 3.3
TSPAN5 4.9 TNFAIP6 3.5 CLDND1 3.3
NPNT 4.6 SMOC2 3.4
Ion transport
KCNN2 3.6 ATP4B 3.1
Proteolysis and inhibition
TLL2 4.8 PRSS35 3.4 SERPINE2 3.0
Transcription regulation
TOX 4.1
Transport
MAL2 4.0 SLC2A3 3.7 NPC1 3.0
Other enzymes
CHST8 8.4 DDAH1 4.4 PLA2G7 3.5
VNN1 6.4 HPSE 4.1 GCLC 3.4
STC1 5.8 MVK 3.7 TRIM2 3.2
PPAP2B 5.5 PDK4 3.6
HSD17B1 4.8 GYLTL1B 3.6
PTGS2 4.6
Other signalling
TPD52L1 7.3 DAB2 3.4 CCND2 3.1
RGS2 4.6 FGD5 3.2 SMAD2 3.1
SORBS2 4.4 RASL11B 3.2
RGMB 3.8 NTS 3.2
Other
ZNF608 4.6 EEPD1 4.4 CAPRIN2 3.5
SUSD4 4.5 LINGO2 3.7 LGALS3 3.1
The level of fold change and statistical significance ( ≥ 3-fold, P < 0.05) was determined by one-way ANOVA with post-hoc Benjamini-Hochberg testing for multiple
corrections. The association of genes with functional terms in this table was determined manually for each gene based on information obtained through the
Entrez Gene database of NCBI. Genes are listed in descending order of fold change in each category.
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Figure 5 Top ten canonical pathways and highly enriched GO terms. Determined for genes differentially regulated between control (± FSH)
and TNFα (± FSH)-treated granulosa cells (n = 527 probe sets, 379 genes mapped to IPA). In (A) the bar charts represent the percentage of genes
from the dataset that map to each canonical pathway in IPA (up regulated in red and down regulated in blue for TNFα (± FSH)-treated granulosa
cells). The line chart ranks the pathways derived from the highest to lowest degree (bottom to top) of association based on the value of a
Benjamini-Hochberg test for multiple corrections. In (B) the bar charts represent the percentage of differentially-regulated genes between control
(± FSH) and TNFα (± FSH)-treated granulosa cells. Only the most specific subcategories of GO terms under biological process which were
considered significant by the Benjamini-Yuketeli test (P < 0.05) were ranked.
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http://www.biomedcentral.com/1471-2164/15/72It is known that TNFα exerts its apoptotic effects
through the Type I receptor (TNFR1), whereas other
pro-inflammatory actions on growth and differentiation
are mediated via the Type II receptor (TNFRII) as previ-
ously reviewed by Matsuda et al. [16]. Since we did not
observe any effect on viable cell number after 4 days ex-
posure to TNFα, this might suggest that TNFα did not
induce apoptosis in the granulosa cells and may act pre-
dominantly via TNFRII in our culture system to activate
a pro-inflammatory cascade that modifies other aspects
of cell function including matrix remodelling and up
regulation of antigen presentation molecules. Many of
the genes whose expression in granulosa cells was up
regulated by TNFα are often associated with innate im-
mune responses. This reinforces recent evidence thatgranulosa cells can act as immune sensors and play an ac-
tive role in initiating protective inflammatory responses to
bacterial pathogens, recognised via interaction of pathogen-
associated molecular patterns (PAMPs) such as lipopolysac-
charide, with toll-like receptor 4 (TLR4) on the cell surface
[21,29,30]. Indeed, bovine granulosa cells were recently
shown to express a full complement of TLRs. Moreover,
functional inflammatory responses to PAMPs interacting
with TLR2 and TLR4 were demonstrated [21].
The genes influenced by TNFα treatment were generally
associated with endocrine function, apoptosis, inflamma-
tion, and degradation as were expected from previous
studies. In our culture system, TNFα alone did not cause
any net loss of cells. Some pro-apoptotic (XAF1, CASP4),
but more anti-apoptotic genes (TGM2, BCL2A1, BIRC3,
Table 4 Upstream regulators determined by IPA to be activated or inhibited by TNFα (± FSH) treatment of cultured
granulosa cells†
Gene symbol or molecule Full gene name Actual fold change Activation z-score P value of overlap
TNF Tumour necrosis factor 6.52 7.03E-39
IFNG Interferon gamma 6.75 6.34E-35
IL1B Interleukin 1, beta 4.76 9.88E-28
Tretinoin All-trans retinoic acid 4.12 7.15E-25
IFNB1 Interferon beta 1 3.66 8.03E-20
OSM Oncostatin M 4.29 5.93E-16
CD40 CD40 molecule, TNF receptor superfamily member 5 10.1 3.25 2.36E-13
TGM2 Transglutaminase 2 31.0 3.34 1.05E-12
FN1 Fibronectin 1 3.3 3.05 7.85E-11
ESR1 Estrogen Receptor 1 3.07 1.99E-07
HTT Huntingtin 3.32 8.34E-07
IL1RN Interleukin 1 receptor antagonist 5.9 −3.60 8.11E-19
†Genes >3-fold differentially regulated between TNFα (± FSH) and control (± FSH) were used for this analysis.
The P value of overlap is the calculated statistical significance of overlap between genes from the dataset and genes that are known to be regulated by the
upstream regulator using Fisher’s exact test.
The bias-corrected z-score is used to infer the activation states of transcriptional regulators. It is calculated from the proportions of genes which are differentially
regulated in an expected direction based on the known interactions between the regulator and the genes present in the Ingenuity database. Those genes with a
z-score greater or less than two are considered to be either activated or inhibited respectively.
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http://www.biomedcentral.com/1471-2164/15/72TNIP1), in fact, appeared to be stimulated by TNFα. It is
likely that the genes which act to block the apoptotic
process are responding as a cellular survival mechanism,
although some may be directly activated via the TNFα
signalling pathway. The blocking effect of TNFα on FSH-
induced oestradiol production has been shown pre-
viously to be suppressed by treatment with peroxisome
proliferator-activated receptor (PPAR) γ ligands [31], and
in this study PPARG expression was inhibited by TNFα,
indicating that this lipid metabolism pathway was alsoFigure 6 The top two networks (A and B) determined in IPA. Genes w
(± FSH)-treated granulosa cells (n = 379 genes mapped to IPA). The netwo
based on the proportion of known interactions between molecules in this
networks were scored at 44 (−log of P value of Fisher’s exact t-test), and m
Interactions between molecules are shown as explained in the legend, wit
down (green) regulation and increasing colour intensity with degree of folinvolved. HSD11B1 encodes a key enzyme in glucocortic-
oid metabolism and has been previously shown to be acti-
vated by TNFα via the regulatory gene CEBPB in cultured
cells [32].
The genes identified as being most highly up regulated
by TNFα include TGM2 (31-fold), GPR77 (62-fold), SLPI
(59-fold) and TNC (52-fold), none of which have previ-
ously been noted in granulosa cells. TGM2 catalyses the
cross-linking of proteins and the conjugation of poly-
amines to proteins. It is also implicated as a positiveere differentially regulated between TNFα (± FSH)-treated and control
rks were generated by a modified triangle connectivity algorithm
dataset (focus molecules) and others in the IPA database. Both
apped 26 genes each from the differentially expressed dataset.
h focus molecule symbols highlighted in colour, based on up (red) or
d change.
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http://www.biomedcentral.com/1471-2164/15/72regulator of the inflammatory response, NF-κB signalling
and cell adhesion [33]. GPR77 (62-fold) is one of several
receptors for the C5a molecule, a major chemotactic and
pro-inflammatory product of the complement cascade ac-
tivated during the innate immune response [34]. SLPI (59-
fold) was first characterised as a protease inhibitor but is
now recognised as having additional properties including
antimicrobial and immunomodulatory activities associated
with the innate immune response. SLPI is up regulated by
pro-inflammatory mediators and appears to have a tissue
protective role [35,36]. TNC (52-fold) is an extracellular
matrix molecule that is highly expressed during embryonic
development but is normally present in low amounts in
adult tissues. However, TNC expression is up regulated in
pathological situations involving tissue injury, wound heal-
ing, inflammation and cancer. TNC influences cell migra-
tion, proliferation and cell signalling pathways through
a variety of mechanisms including induction of pro-
inflammatory cytokines [37].
Conclusions
In vitro, the transcriptome of granulosa cells responded
minimally to FSH compared with the response to TNFα.
The response to TNFα indicated a reduction in endo-
crine function and an active process akin to tissue repair
and remodelling as would occur upon atresia. Addition-
ally there was an inflammatory response to TNFα that
displays many features normally associated with immune
cells.
Methods
Bovine ovaries and primary culture of granulosa cells
Bovine granulosa cells were isolated from adult bovine
ovaries obtained from a local abattoir as described previ-
ously [17,18,38]. Contamination with theca cells was
judged to be < 1% based on comparison of the relative
expression of CYP17A1 and LHCGR in freshly isolated
granulosa cells and theca cells as determined by qRT-
PCR (data not shown). For each experiment cells were
pooled from approximately 50 individual 4–6 mm folli-
cles and seeded at 5×105 viable cells/ml into 24-well
(microarray) or 75,000 cells/0.2 ml into 96 well plates
(dose response) with four replicate wells per treatment.
Cells were cultured for six days under defined serum-
free conditions. The culture medium used consisted of
McCoy’s 5A modified medium supplemented with 1%
(v/v) antibiotic-antimycotic solution, 10 ng/ml bovine in-
sulin, 2 mM L-glutamine, 10 mM HEPES, 5 μg/ml apo-
transferrin, 5 ng/ml sodium selenite and 0.1% (w/v) BSA
(all purchased from Sigma UK Ltd, Poole, Dorset, UK).
The culture medium was supplemented with 10-7 mol/l
androstenedione (Sigma UK Ltd, Poole, Dorset, UK) as a
substrate for cytochrome P450 aromatase. Media were
removed after 48 h and 96 h and replaced with freshmedia containing treatments described below. Condi-
tioned media were retained for hormone assays, and at
the end of culture either viable cell number was deter-
mined (dose–response experiment) by neutral red up-
take assay [17] or cell lysates were prepared (microarray
experiment) using the lysis buffer component of the
RiboPure RNA isolation kit (Ambion/ Life Technologies
Ltd., Paisley, UK). Pooled lysates from replicate wells
were stored at -80C until total RNA isolation. Each ex-
periment was repeated four times using cells harvested
from independent batches of ovaries.
Treatments
Highly purified ovine FSH (NIADDK oFSH-19SIAPP) was
supplied by NHPP, Torrance, CA, USA. Recombinant hu-
man TNFα was purchased from Sigma Aldrich, St Louis,
MO, USA (Cat# T6674 with a stated endotoxin level <1
ng/ug). Treatments were dissolved in Hank’s balanced-salt
solution containing 0.1% (w/v) BSA and stock solutions
sterilized using 0.2 μm membrane filters before dilution in
the culture medium. These treatments were applied on
days 3 to 6 of culture for both the microarray and
dose response experiments under the conditions specified
above.
Steroid immunoassays
The concentrations of oestradiol in conditioned media
were determined by radioimmunoassay [39]. The detec-
tion limit of the assay was 2 pg/ml and mean intra- and
inter-assay CVs were 6% and 9% respectively. Concen-
trations of progesterone in conditioned media were de-
termined by competitive ELISA [40]. The detection limit
was 0.1 ng/ml and mean intra- and inter-assay CVs were
8% and 11% respectively.
Total RNA isolation, microarray analysis and quantitative
RT-PCR
Total RNA was isolated from cultured cells for microarray
analysis and for validation using qRT-PCR. RNA was iso-
lated using the RiboPure™ RNA isolation kit (Ambion) ac-
cording to the manufacturer’s instructions. RNA yield and
quality were evaluated by spectrophotometry at 260/
280 nm and agarose gel electrophoresis before submitting
samples (n = 16) to an accredited Affymetrix service
provider (Almac Diagnostics Ltd, Craigavon, Northern
Ireland) for microarray analysis. For qRT-PCR analysis,
first strand cDNA was synthesized from 1 μg of total RNA
using the Reverse-iT™ reverse transcription kit (used
according to manufacturer’s protocol; Abgene, Epsom,
Surrey, UK) in a 20 μl reaction primed with random hex-
amers. Primers (see Table 5) were designed to amplify tar-
get sequences using Primer Express software (Applied
Biosystems/ Life Technologies Ltd) or the online Primer
Design Tool (NCBI/Primer-BLAST). In primer validation
Table 5 List of primers used for qRT-PCR
Target Genbank accession number Forward primer 5′ to 3′ Reverse primer 5′ to 3′ Amplicon size (bp)
FSHR NM_174061 GCCAGCCTCACCTACCCCAGC AATTGGATGAAGGTCAGAGGTTTGCC 75
STAR NM_174189 TTTTTTCCTGGGTCCTGACAGCGTC ACAACCTGATCCTTGGGTTCTGCACC 103
CYP11A1 NM_176644 CAGTGTCCCTCTGCTCAACGTCC TTATTGAAAATTGTGTCCCATGCGG 99
HSD3B1 NM_174343 GCCACCTAGTGACTCTTTCCAACAGCG TGGTTTTCTGCTTGGCTTCCTCCC 111
HSD17B1 NM_001102365 CGCATATTGGTGACCGGGAGCATA AATCGCCAGACTCTCGCACAAACC 108
CYP19A1 NM_174305 CGCCACTGAGTTGATTTTTGCTGAGA TAAGGCTTTGCGCATGACCAGGTC 301
ACTB NM_173979 ATCACCATCGGCAATGAGCGGTTC CGGATGTCGACGTCACACTTCATGA 128
INHBA NM_174363 GAAGAGACCCGATGTCACCCAGC TGTCGTCCTCTATCTCCACGTACCCG 113
INHA NM_174094 GAGCCCGAGGACCAAGATGTCTCC CCTCAGCCTCTCCAGCATCTGGC 91
FST NM_175801 TGAGCAAGGAGGAGTGTTGCAGCA CATCTGGCCTTGAGGAGTGCACATTC 301
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electrophoresis were used to verify that each primer pair
generated a single product of the predicted size. cDNA
template log-dilution curves were used to demonstrate sat-
isfactory PCR efficiency (> 85%) and linearity. PCR assays
were carried out in a volume of 14 μl, comprising 5 μl
cDNA template (1/50 dilution), 1 μl each forward and re-
verse primers (final concentration 0.4 μM) and 7 μl Quan-
tiTect SYBR Green qPCR 2x Master Mix (Qiagen Ltd.,
Crawley, west Sussex, UK). Samples were processed on a
StepOneTM Plus real-time PCR instrument (Applied Bio-
systems/ Life Technologies Ltd.) with the following thermal
cycling conditions: 15 min at 95°C (one cycle) followed by
15 s at 95°C and 1 min at 60°C (40 cycles).
For qRT-PCR analyses, the ΔΔCt method [41] was used
for comparison of the relative abundance of each mRNA
transcript. Ct values for each transcript in a given sample
were first normalised to the β-actin Ct value (which was
uniform across all experimental groups: ANOVA P > 0.1).
Resultant ΔCt values for individual replicates within each
treatment group were then normalised to the average ΔCt
value of the respective vehicle-treated control group.
These ΔΔCt values were finally converted to fold differ-
ences using the formula: fold difference = 2(−ΔΔCt).
Statistical analyses
Results for hormone secretion (during final 96–144 h
period of culture) were analysed using two-way ANOVA
and are presented as means ± SEM based on four inde-
pendent culture experiments. To reduce heterogeneity of
variance, hormone data were log-transformed prior to stat-
istical analysis. qRT-PCR data (from n = 4 independent
granulosa cell batches) were statistically analysed (ANOVA
and post-hoc Fisher’s LSD test) as ΔCt values before con-
version to fold-difference values for graphical presentation.
Microarray
Following confirmation of the quality of the RNA and
cDNA synthesis, hybridisations to GeneChip® BovineGenome Arrays (Affymetrix, CA, USA) and scanning were
performed according to Affymetrix protocols at the Almac
Diagnostics Facility. All samples were analysed together as
one lot using the same batch of arrays. First-strand cDNA
synthesis was performed on two micrograms of RNA
using a T7-linked oligo-dT primer, followed by second
strand synthesis. In vitro transcription reactions were per-
formed in batches to generate biotinylated cRNA targets,
which were subsequently chemically fragmented at 95°C
for 35 min. Ten μg of the fragmented, biotinylated cRNA
was hybridized at 45°C for 16 h to Affymetrix GeneChip
Bovine Genome Arrays, which contain 24,128 probe sets
representing over 23,000 transcripts and variants, includ-
ing 19,000 UniGene clusters. The arrays were then washed
and stained with streptavidin-phycoerythrin (final concen-
tration 10 μg/ml). Signal amplification was achieved by
using a biotinylated anti-streptavidin antibody. The array
was then scanned according to the manufacturer’s instruc-
tions. The scanned images were inspected for the presence
of any defect (artefact or scratch) on the array.
Treatment and analysis of microarray data
Non-biological signal variation due to possible array differ-
ences or hybridisation treatments were minimised by nor-
malisation of the raw data using the Robust Multi-array
Average (RMA) method [42,43] with adjustments as de-
tailed previously [44,45]. The normalisation and statistical
analyses were performed in Partek Genomics Suite Soft-
ware version 6.5 (Partek Incorporated, St Louis, MO, USA).
Array quality controls were performed by spike-in analysis
of standard amounts of bacterial specific cDNA against re-
spective homologous probe sets on the chip. Statistical dif-
ferences between treatment groups were determined by
one-way ANOVA with FDR tests for multiple comparisons.
The fold change in gene expression was determined from
the non log-transformed signal data after correction and
normalisation. The experimental details and array CEL data
files have been deposited under series name GSE42535 in
NCBI’s Gene Expression Omnibus (GEO) database.
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The groups of differentially expressed genes were up-
loaded into the Ingenuity Pathway Analysis (IPA) database
for network and pathway determination (Ingenuity Sys-
tems, 2005). These datasets were also characterised ac-
cording to their association with Gene Ontology (GO)
terms listed under biological process using Gene Ontology
Enrichment Analysis Software Toolkit (GOEAST) [46].
Additional files
Additional file 1: Figure S1. Unsupervised hierarchical clustering across
all probe sets (n = 24,182) for 16 arrays using the Euclidian dissimilarity
algorithm with the average linkage method in Partek Genomics Suite.
The heatmap represents the distribution of normalised signal intensity,
grouped by pattern similarity for both probe set and array (indicated by
dendrogram at top).
Additional file 2: Figure S2. Principal component analyses of probe set
intensity for all TNFα treatment arrays (n = 8) A, and FSH-treated and
control arrays (n = 7) B. In A the arrays are numbered TNFα-treated
(G3, G7, G11 and G15 in red) and TNFα plus FSH-treated (G4, G8, G12,
and G16 in black). In B, the arrays are numbered (n = 4 per treatment) as
follows: control granulosa (G1, G5, G9 and G13 in grey); FSH-treated
(G2, G6, G10 and G14 in blue). The graph is a scatter plot of the values
for the first (X) and second (Y) principal components based on the
correlation matrix of the total normalised array intensity data.
Additional file 3: Figure S3. Venn diagram of numbers of genes
differentially regulated between TNFα ± FSH treatments and the control.
Symbols indicate genes which are up (↑) and down regulated (↓).
Additional file 4: Table S1. The numbers of probe sets which were
differentially regulated between TNFα ± FSH treatments of cultured
granulosa and the control. The numbers were determined by a one-way
ANOVA with an FDR of P < 0.05 for multiple comparisons using Partek.
Additional file 5: Table S2. A list of probe sets (n = 527) which are
3-fold differentially regulated between control (± FSH) (n = 7) and TNFα
(± FSH)-treated (n = 8) groups with an FDR of P < 0.05 for multiple
comparisons. The probe sets are listed in alphabetical order based on
gene symbol, and those which have not been assigned a gene
annotation have been placed at the end of the list.
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